Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Douglas C. A. Taylor, Jessica L. Abel, Carolyn Martin, Jalpa A. Doshi, Breanna Essoi, Stephanie Korrer, David S. Reasner, Robyn T. Carson & Alyssa Goolsby Hunter. (2020) Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR). Journal of Medical Economics 23:10, pages 1072-1083.
Read now
Read now
Emanuele Sinagra, Francesca Rossi, Dario Raimondo, Giuseppe Conoscenti, Andrea Anderloni, Valentina Guarnotta & Marcello Maida. (2020) Tenapanor for the treatment of irritable bowel syndrome with constipation. Expert Review of Clinical Pharmacology 13:5, pages 473-479.
Read now
Read now
Charles F. Barish, Robert A. Crozier & Patrick H. Griffin. (2019) Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation. Current Medical Research and Opinion 35:1, pages 81-85.
Read now
Read now
Laura Sirri, Silvana Grandi & Eliana Tossani. (2017) Smoking in Irritable Bowel Syndrome: A Systematic Review. Journal of Dual Diagnosis 13:3, pages 184-200.
Read now
Read now
Caitlyn T. Solem, Haridarshan Patel, Sonam Mehta, Reema Mody, Cynthia Macahilig & Xin Gao. (2016) Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype. Current Medical Research and Opinion 32:5, pages 899-905.
Read now
Read now
Huan Huang, Douglas C. A. Taylor, Robyn T. Carson, Phil Sarocco, Mark Friedman, Michael Munsell, Steven I. Blum & Joseph Menzin. (2015) Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States. Journal of Medical Economics 18:4, pages 283-294.
Read now
Read now
Annie Guerin, Robyn T. Carson, Barbara Lewis, Donald Yin, Michael Kaminsky & Eric Wu. (2014) The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population. Journal of Medical Economics 17:8, pages 577-586.
Read now
Read now
Brooks D. Cash. (2014) Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome. Current Medical Research and Opinion 30:7, pages 1405-1415.
Read now
Read now
Jan Tack. (2013) How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?. Expert Review of Gastroenterology & Hepatology 7:sup1, pages 21-26.
Read now
Read now
Marco daCosta DiBonaventura, Mercedes Prior, Pablo Prieto & Josep Fortea. (2012) Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom. Clinical and Experimental Gastroenterology 5, pages 203-212.
Read now
Read now
Articles from other publishers (37)
Anthony J. Lembo, Keith A. Friedenberg, Ronald P. Fogel, Susan Edelstein, Suling Zhao, Yang Yang, David P. Rosenbaum & William D. Chey. (2023)
Long‐term safety of tenapanor in patients with irritable bowel syndrome with constipation in the
T3MPO
‐3 study
. Neurogastroenterology & Motility 35:11.
Crossref
Crossref
Åsa Frändemark, Hans Törnblom, Magnus Simrén & Sofie Jakobsson. (2022) Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome. BMC Gastroenterology 22:1.
Crossref
Crossref
Brian E. Lacy, Darren M. Brenner & William D. Chey. (2022) Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data. Clinical Gastroenterology and Hepatology 20:4, pages e682-e695.
Crossref
Crossref
Alex Exuzides, Joana E. Matos, Anisha M. Patel, Ashley A. Martin, Bryan Ricker & Danny Bega. (2022) Understanding the Burdens Associated with Huntington’s Disease in Manifest Patients and Care Partners–Comparing to Parkinson’s Disease and the General Population. Brain Sciences 12:2, pages 161.
Crossref
Crossref
Tingting Zhao, Lixia Pei, Houxu Ning, Jing Guo, Yafang Song, Junling Zhou, Lu Chen, Jianhua Sun & Zhongping Mi. (2021) Networks Are Associated With Acupuncture Treatment in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Resting-State Imaging Study. Frontiers in Human Neuroscience 15.
Crossref
Crossref
Jinsheng Wang, Pengcheng Yang, Lei Zhang & Xiaohua Hou. (2021) A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Frontiers in Nutrition 8.
Crossref
Crossref
Eric D. ShahBrian E. LacyWilliam D. CheyLin ChangDarren M. Brenner. (2021) Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials. American Journal of Gastroenterology 116:8, pages 1601-1611.
Crossref
Crossref
Toshihiko Tomita, Kiyoyasu Kazumori, Kenji Baba, Xiahong Zhao, Yirong Chen & Hiroto Miwa. (2020) Impact of chronic constipation on health‐related quality of life and work productivity in Japan. Journal of Gastroenterology and Hepatology 36:6, pages 1529-1537.
Crossref
Crossref
Klaus Bielefeldt. (2020) Perceived Barriers to Treatment in Persons Treated for Functional Gastrointestinal Disease with Constipation. Digestive Diseases and Sciences 66:3, pages 739-750.
Crossref
Crossref
Pei-Lin Yang, Robert L. Burr, Diana T. Buchanan, Kenneth C. Pike, Kendra J. Kamp & Margaret M. Heitkemper. (2020) Indirect effect of sleep on abdominal pain through daytime dysfunction in adults with irritable bowel syndrome. Journal of Clinical Sleep Medicine 16:10, pages 1701-1710.
Crossref
Crossref
Åshild Faresjö, Susanna Walter, Anna-Karin Norlin, Tomas Faresjö & Michael P. Jones. (2019) Gastrointestinal symptoms - an illness burden that affects daily work in patients with IBS. Health and Quality of Life Outcomes 17:1.
Crossref
Crossref
Jacqueline A. Nicholas, Batul Electricwala, Lulu K. Lee & Kristen M. Johnson. (2019) Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data. BMC Neurology 19:1.
Crossref
Crossref
Douglas C.A. Taylor, Jessica L. Abel, Jalpa A. Doshi, Carolyn Martin, Alyssa Goolsby Hunter, Breanna Essoi, Stephanie Korrer, David S. Reasner, Robyn T. Carson & William D. Chey. (2019) The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications. Journal of Clinical Gastroenterology 53:10, pages 737-743.
Crossref
Crossref
Blanca Serrano-Falcón, Sílvia Delgado-Aros, Fermín Mearin, Constanza Ciriza de los Ríos, Jordi Serra, Miguel Mínguez, Miguel Montoro Huguet, Antonia Perelló, Cecilio Santander, Ángeles Pérez Aisa, Inmaculada Bañón-Rodríguez & Enrique Rey. (2019) Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms. Therapeutic Advances in Gastroenterology 12, pages 175628481985735.
Crossref
Crossref
Åsa Frändemark, Hans Törnblom, Sofie Jakobsson & Magnus Simrén. (2018) Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. American Journal of Gastroenterology 113:10, pages 1540-1549.
Crossref
Crossref
Eamonn M. M. Quigley, John Horn, Michele Kissous-Hunt, Robert A. Crozier & Lucinda A. Harris. (2018) Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire. Advances in Therapy 35:7, pages 967-980.
Crossref
Crossref
Kyle Staller, Kenneth Barshop, Braden Kuo & Ashwin N. Ananthakrishnan. (2018) Depression but Not Symptom Severity is Associated With Work and School Absenteeism in Refractory Chronic Constipation. Journal of Clinical Gastroenterology 52:5, pages 407-412.
Crossref
Crossref
Darren M. Brenner, Ronald Fogel, Spencer D. Dorn, Richard Krause, Paul Eng, Robert Kirshoff, Anhthu Nguyen, Robert A. Crozier, Leslie Magnus & Patrick H. Griffin. (2018) Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. American Journal of Gastroenterology 113:5, pages 735-745.
Crossref
Crossref
Tomomitsu Tahara, Kazuya Takahama, Sayumi Tahara, Dai Yoshida, Noriyuki Horiguchi, Tomohiko Kawamura, Masaaki Okubo, Mitsuo Nagasaka, Yoshihito Nakagawa, Makoto Urano, Tomoyuki Shibata, Tetsuya Tuskamoto, Hiro-o Ieda, Makoto Kuroda & Naoki Ohmiya. (2017) Endoscopic features of lymphoid follicles using blue laser imaging (BLI) endoscopy in the colorectum and its association with chronic bowel symptoms. PLOS ONE 12:8, pages e0182224.
Crossref
Crossref
Jessica L. Buono, Robyn T. Carson & Natalia M. Flores. (2017) Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health and Quality of Life Outcomes 15:1.
Crossref
Crossref
Paul S. J. Miller, Harry Hill & Fredrik L. Andersson. (2016) Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases. PharmacoEconomics 34:12, pages 1277-1297.
Crossref
Crossref
Brian E. Lacy, Haridarshan Patel, Annie Guérin, Katherine Dea, Justin L. Scopel, Reza Alaghband, Eric Qiong Wu & Reema Mody. (2016) Variation in Care for Patients with Irritable Bowel Syndrome in the United States. PLOS ONE 11:4, pages e0154258.
Crossref
Crossref
Paul Enck, Johannes Leinert, Menno Smid, Thorsten Köhler & Juliane Schwille-Kiuntke. (2016) Somatic Comorbidity in Chronic Constipation: More Data from the GECCO Study. Gastroenterology Research and Practice 2016, pages 1-8.
Crossref
Crossref
A. Dudekula, S. Huftless & K. Bielefeldt. (2015) Colectomy for constipation: time trends and impact based on the US Nationwide Inpatient Sample, 1998–2011. Alimentary Pharmacology & Therapeutics 42:11-12, pages 1281-1293.
Crossref
Crossref
Elizabeth J. Videlock & Lin Chang. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1495
1521
.
Sanda Pletikosic, Ivana Plavsic, Goran Hauser & Mladenka Tkalcic. (2015) Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity. Medical Hypotheses 85:3, pages 339-342.
Crossref
Crossref
Shahnaz Mohammadi, Maryam Izadi-Mazi & Mahsa Akbarian-F. (2015) Anxiety and Quality of Life in patients with Irritable Bowel Syndrome. Journal of Medical Sciences 15:5, pages 235-240.
Crossref
Crossref
Brian L. Pike, Katie Ann Paden, Ashley N. Alcala, Kayla M. Jaep, Robert P. Gormley, Alexander C. Maue, Benjamin S. Christmann, Charles O. Elson, Mark S. Riddle & Chad K. Porter. (2015) Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome. Journal of Travel Medicine 22:4, pages 242-250.
Crossref
Crossref
Magdy El-Salhy. (2015) Recent developments in the pathophysiology of irritable bowel syndrome. World Journal of Gastroenterology 21:25, pages 7621.
Crossref
Crossref
Kelly Parsons, Julius Goepp, Bryan Dechairo, Elizabeth Fowler, Nathan Markward, Patrick Hanaway, Teresa Mcbride & Darryl Landis. (2014) Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The Imminent Study. Global Advances in Health and Medicine 3:3, pages 25-32.
Crossref
Crossref
Julius Goepp, Elizabeth Fowler, Teresa Mcbride & Darryl Landis. (2014) Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome. Global Advances in Health and Medicine 3:3, pages 9-15.
Crossref
Crossref
B. E. Lacy, A. J. Lembo, J. E. MacDougall, S. J. Shiff, C. B. Kurtz, M. G. Currie & J. M. Johnston. (2013)
Responders
vs
clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in
IBS
‐C
. Neurogastroenterology & Motility 26:3, pages 326-333.
Crossref
Crossref
P. Layer & V. Stanghellini. (2014) Review article: linaclotide for the management of irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics 39:4, pages 371-384.
Crossref
Crossref
Renée M. Marchioni Beery & Reena V. Chokshi. 2014. Constipation. Constipation
1
20
.
Magnus Simrén & Hans TörnblomMonica E Jarrett & Margaret M Heitkemper. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
57
79
.
E. M. M. Quigley, J. Tack, W. D. Chey, S. S. Rao, J. Fortea, M. Falques, C. Diaz, S. J. Shiff, M. G. Currie & J. M. Johnston. (2012)
Randomised clinical trials: linaclotide phase 3 studies in
IBS
‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints
. Alimentary Pharmacology & Therapeutics 37:1, pages 49-61.
Crossref
Crossref
Young Ah Goo, Kevin Cain, Monica Jarrett, Lynne Smith, Joachim Voss, Ernie Tolentino, Joyce Tsuji, Yihsuan S. Tsai, Alexandre Panchaud, David R. Goodlett, Robert J. Shulman & Margaret Heitkemper. (2012) Urinary Proteome Analysis of Irritable Bowel Syndrome (IBS) Symptom Subgroups. Journal of Proteome Research 11:12, pages 5650-5662.
Crossref
Crossref